Yipeng Cheng

Feb 15, 2024 | medrxiv.org | Yipeng Cheng |Christian Gieger |Archie Campbell |Andrew McIntosh |Andrew Mcintosh

R.E.M is an advisor to the Epigenetic Clock Development Foundation and Optima Partners. All other authors declare no competing interests. This research was funded in whole, or in part, by the Wellcome Trust [104036/Z/14/Z, 108890/Z/15/Z, 216767/Z/19/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.

Apr 7, 2023 | inkl.com | Yipeng Cheng

Alongside this, other risk factors such as age, sex, BMI and family history were examined in about 15,000 volunteers to predict the likelihood of developing the condition years in advance of any symptoms developing. The findings could lead to preventative measures being put in place earlier, reducing the economic and health burden caused by the disease. Researchers found that the inclusion of DNA methylation data alongside the other commonly used risk factors provided a more accurate prediction.